Production (Stage)
Leap Therapeutics, Inc.
LPTX
$0.393
-$0.0022-0.56%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -69.40M | -67.79M | -64.59M | -60.11M | -53.37M |
| Total Depreciation and Amortization | -100.00K | -95.00K | -91.00K | -88.00K | -84.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.25M | 6.30M | 4.80M | 5.25M | 5.35M |
| Change in Net Operating Assets | 3.99M | 1.29M | 4.71M | 4.89M | 1.54M |
| Cash from Operations | -59.26M | -60.30M | -55.17M | -50.06M | -46.57M |
| Capital Expenditure | -- | -- | 0.00 | 0.00 | -348.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 0.00 | 0.00 | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 0.00 | 0.00 | -348.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -77.00K | -- | -- | -- | -- |
| Issuance of Common Stock | 40.12M | 40.13M | 40.03M | 40.03M | 29.00K |
| Repurchase of Common Stock | -- | -- | 0.00 | -1.00K | -1.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.95M | -2.95M | -2.95M | -2.88M | 0.00 |
| Cash from Financing | 37.09M | 37.18M | 37.08M | 37.15M | 28.00K |
| Foreign Exchange rate Adjustments | -39.00K | -279.00K | 167.00K | -26.00K | -228.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -22.21M | -23.39M | -17.92M | -12.94M | -47.12M |